ImaRx Therapeutics (Urokinase Business) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

ImaRx Therapeutics (Urokinase Business) General Information

Description

Manufacturer of bio pharmaceutical products. The company manufactures thrombolytic which is used in treatment of acute massive pulmonary embolism.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Microbix Biosystems
Primary Office
  • 6860 Lexington Avenue
  • Suite 120
  • Los Angeles, CA 90038
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ImaRx Therapeutics (Urokinase Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.

Request a free trial

ImaRx Therapeutics (Urokinase Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImaRx Therapeutics (Urokinase Business)‘s full profile, request access.

Request a free trial